ResMed’s Pendarvis to retire 

SAN DIEGO – ResMed has announced that David Pendarvis, chief administrative officer, global general counsel and secretary, plans to retire on June 30.  He will remain in a consulting role with the company through Dec. 31, 2023. “Dave has been an integral part of ResMed for over 20 years, helping guide the company into and through its transformation from the pioneer of sleep apnea treatment to a $30 billion-plus global leader in digital health and cloud-connected medical devices,” said CEO Mick Farrell. “On behalf of the entire management team and the board, I want to thank Dave for his two decades of dedicated service and exemplary leadership that has helped build the industry-leading company that ResMed is today. He’s been an important leader in an executive team that has positioned ResMed to improve the lives of many millions of people living with chronic respiratory diseases and countless more seeking to age healthily and outside the hospital. Personally, Dave has been a trusted advisor, partner, friend, and mentor to me through the years, I will miss his guidance, insights, and quick sense of humor.” ResMed has appointed Amy Wakeham, its current vice president of corporate communications & investor relations, as chief communications and investor relations officer to succeed Pendarvis in his role leading corporate public affairs. She will report to the office of the CEO and has joined the company’s executive leadership team. ResMed will conduct an internal search for a new global general counsel and secretary and expects to name a replacement well ahead of Pendarvis’ retirement date to ensure a smooth and seamless transition.